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Fighting viral infections is hampered by the scarcity
of viral targets and their variability, resulting in devel-
opment of resistance. Viruses depend on cellular
molecules—which are attractive alternative tar-
gets—for their life cycle, provided that they are
dispensable for normal cell functions. Using the
model organism Drosophila melanogaster, we iden-
tify the ribosomal protein RACK1 as a cellular factor
required for infection by internal ribosome entry site
(IRES)-containing viruses. We further show that
RACK1 is an essential determinant for hepatitis C
virus translation and infection, indicating that its
function is conserved for distantly related human
and fly viruses. Inhibition of RACK1 does not affect
Drosophila or human cell viability and proliferation,
and RACK1-silenced adult flies are viable, indicating
that this protein is not essential for general transla-
tion. Our findings demonstrate a specific function
for RACK1 in selective mRNA translation and un-
cover a target for the development of broad antiviral
intervention.
INTRODUCTION
Viral infections are a significant threat for all living organisms. In
humans, acute and chronic viral infections cause a wide spec-
trum of diseases, including life-threatening inflammation and
cancer. A major challenge for the control of viral infections is
that viruses, due to the small size of their genomes, offer few
intrinsic targets either for recognition by the immune system or
for inhibition by antiviral effector molecules. Furthermore, the er-
ror-prone viral polymerases allow RNA viruses to rapidly escape
detection by the immune systemand to resist the adverse effects
of directly acting antiviral molecules. Significantly, viruses rely on
numerous host factors for essential functions during their life cy-1086 Cell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc.cle. These are not subject to rapid sequence changes and hence
provide good alternative targets for antiviral therapy. Therefore,
a central challenge is to identify cellular factors required for viral
replication but dispensable for normal cell function.
RNA replication, transcription, and translation are critical
steps in the life cycle of RNA viruses that involve interactions
with host-cell molecules. In the model organism Drosophila
melanogaster, the small interfering RNA (siRNA) pathway tar-
gets viral RNAs (reviewed in Ding [2010]). In order to better
characterize the contribution of the three core components of
this pathway, Dicer-2, R2D2, and AGO2, we performed a pro-
teomic analysis of the complexes assembling around these
molecules in infected Drosophila cells (K.M., J.-L.I., Y.V., and
J.V., unpublished data). One protein copurifying with R2D2
and AGO2 in cells infected with the picorna-like Drosophila C
virus (DCV) was the evolutionarily conserved ribosomal protein
RACK1. The RACK1 protein has been extensively studied dur-
ing the last two decades and has been shown to be involved in
different aspects of cell regulation. RACK1 is an adaptor pro-
tein, interacting with a variety of signaling molecules (e.g.,
PKC, Src, and MAPK) (Belozerov et al., 2014; Gibson, 2012;
Long et al., 2014) and is a component of the 40S subunit of
the ribosome (Coyle et al., 2009; Sengupta et al., 2004).
RACK1 is thus ideally suited to connect signal transduction
pathways to the regulation of translation (Nilsson et al., 2004).
Indeed, RACK1 was found to interact with the initiation factor
eIF6, which associates with the 60S subunit of the ribosome
and prevents its association with the 40S subunit. eIF6 phos-
phorylation by RACK1-assisted PKC triggers its release from
the 60S subunit, thus promoting the formation of 80S active ri-
bosomes (Ceci et al., 2003).
Here, we show that RACK1 is mandatory for DCV replication
but is largely dispensable for cell viability and proliferation.
We further demonstrate that RACK1 is required for internal ribo-
some entry site (IRES)-dependent translation in Drosophila and
in human hepatocytes, where this factor is an essential deter-
minant of hepatitis C virus infection. By contrast, RACK1 is
not required for 50 cap-dependent translation. Collectively, our
data unravel a specific function for ribosomal protein RACK1
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Figure 1. RACK1 Is Required for DCV Replication, but Not for
Viability or Proliferation in Drosophila Cells
(A and B) Quantification of DCV viral RNA levels by qRT-PCR (A) and of cell
numbers as estimated by DAPI staining (B) in cells treated with the indicated
dsRNAs to induce silencing. Cells treated with a dsRNA corresponding to GFP
and AGO2 sequences are used as a reference and a control, respectively.
(C) S2 cells stably transfected with a metallothionein promoter-driven vector
expressing a shRNA targeting the 50 UTR from theRACK1 genewere treated or
not with CuSO4 for 3 days, stained with DAPI and an anti-phospho-H3 anti-
body (left), and counted (right).
Data represent the mean and SEM of at least three independent experiments.
ns, nonsignificant; *p < 0.05. See also Figure S1 and Table S1.in selective mRNA translation of fly and human viruses and
uncover a target for the development of broad antiviral
intervention.
RESULTS
RACK1 Is Required for Dicistroviridae Infection in
Drosophila
In a proteomic analysis of the interactome of Dicer-2, R2D2, and
AGO2 in virus-infected cells (K.M., J.-L.I., Y.V., and J.V., unpub-
lished data), we identified 16 ribosomal proteins. To address the
functional relevance of this finding, we systematically depleted
these ribosomal proteins from S2 cells by RNAi and tested
DCV replication. Knockdown of most ribosomal genes affected
cell viability or proliferation and did not yield interpretable results
regarding DCV infection (Figures 1A and 1B). Indeed, silencing of
these genes may result in decreased ability of the cells either toCsupport viral replication or to control the infection. By contrast,
depletion of RACK1 (Figure S1A available online) did not affect
cell viability or proliferation in S2 cells (Figures 1B and 1C) or in
two other cell lines (Figure S1B). However, it resulted in a signif-
icant decrease of DCV titer in infected cells (Figure 1A). Further-
more, RACK1 silencing did not affect replication of either flock
house virus (FHV) or vesicular stomatitis virus (VSV) (Figures 2A
and 2B), indicating that the RACK1-depleted cells are not only
viable and able to proliferate but can also support replication
of other viruses. To test whether the effect of RACK1 was spe-
cific to DCV or to the family to which it belongs, we infected S2
cells with Cricket Paralysis Virus (CrPV), another member of
the Dicistroviridae family. Replication of CrPV was also strongly
impaired when RACK1 was depleted (Figure 2B).
We next confirmed these findings in vivo. RACK1 null mutant
flies are not viable, indicating that RACK1 exerts developmental
functions (Kadrmas et al., 2007). In agreement with this finding,
silencing RACK1 expression with a small hairpin RNA (shRNA)
driven by the broadly active actin5C promoter was embryonic
lethal. When the thermosensitive Gal80 system was used to ex-
press the shRNA only in adult flies, development occurred nor-
mally and the adult flies expressed significantly reduced levels
of RACK1 at the permissive temperature of 29C (Figure 2C).
The reduced levels of RACK1 did not affect the viability of the
flies, although it reduced longevity by 20% at this temperature.
In addition, the eggs laid by RACK1-silenced females showed
a phenotype similar to that of RACK1 mutants (Figure S1C)
(Kadrmas et al., 2007). Thus, even though RACK1 is required
during development, it appears to be largely dispensable in adult
flies. As expected, when these flies were challenged with DCV,
both viral RNA and capsid protein levels were markedly reduced
at 1 and 2 days postinfection compared to controls (Figure 2D).
Overall, our data indicate that replication of the Dicistroviridae
DCV and CrPV requires the ribosomal factor RACK1, which is
otherwise dispensable for the viability of S2 cells and adult flies.
RACK1 Is Required for Viral IRES-Dependent
Translation
Our data indicate that RACK1 is required for a step of viral repli-
cation specific to Dicistroviridae. Whereas FHV and VSV use a
canonical strategy of cap-dependent initiation of translation,
DCV and CrPV RNA recruits the 40S ribosomal subunit through
IRES sequences to initiate translation (Figure S2A). Furthermore,
although initially identified as a scaffolding protein involved in
protein kinase C signaling, RACK1 is now recognized as a
component of the 40S subunit of the ribosome. This suggested
to us that RACK1 was required for viral translation. We first veri-
fied that RACK1 is indeed required at the ribosome level for CrPV
replication. We silenced RACK1 expression in a stable cell line
using an shRNA targeting the 50 UTR (Figure S1D) and observed
amarked decrease in CrPV replication (Figure S1E). Transfection
of a vector expressing wild-type RACK1 restored CrPV replica-
tion in these cells (Figure 3A). By contrast, expression of mutant
proteins unable to interact with either RpS17 (D108Y) (Kuroha
et al., 2010) or 18S rRNA (R38D/K40E) (Coyle et al., 2009) did
not rescue CrPV replication (Figure 3A). We conclude that
RACK1 is required in the 40S ribosomal subunit for CrPV
replication.ell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc. 1087
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Figure 2. RACK1 Is Required for Replication
of DCV and CrPV, but Not FHV and VSV
(A and B) S2 cells were treated with either control
(GFP) or RACK1 dsRNA for 4 days before chal-
lenge with DCV, FHV, VSV, or CrPV. Viral infection
was monitored by immunofluorescence using
antibodies recognizing capsid proteins (A) and
qRT-PCR (B) after 16 hr or, in the case of VSV, after
48 hr. The percentage of infected cells is indicated
for each virus in (A).
(C) Silencing of RACK1 expression in transgenic
flies expressing a shRNA targeting the 50 UTR from
the RACK1 gene using the Gal4-UAS system and
the broadly expressed actin-Gal4 driver controlled
by the thermosensitive (TS) tub-Gal80 repressor. A
shRNA targeting the mCherry protein was used as
a control. The lifespan of RACK1-depleted flies is
shown in the bottom graph.
(D) RACK1-silenced flies infected by DCV after
5 days at 29C show a decrease of the viral RNA
and protein, as indicated by qRT-PCR (top) and
western blot.
Data represent the mean and SEM from at least
three independent experiments. ns, nonsig-
nificant; dpi, days postinfection; *p < 0.05, **p <
0.01, and ***p < 0.001. See also Figures S1
and S2.To confirm that RACK1 is involved in translation from Dicis-
troviridae RNAs, we tested whether its depletion affected trans-
lation of luciferase reporters placed under the control of the two
IRES elements from CrPV (Figures 3B and S2C). Translation of
a 50 cap-dependent RNA was not affected in the absence of
RACK1, although it was affected when expression of eIF4E
was knocked down. Translation from the CrPV 50 IRES reporter
was not reduced, and was even slightly increased, when eIF4E
was silenced, suggesting that the 50 IRES drives noncanonical
translation. Interestingly, a significant reduction of luciferase
production was observed for the 50 IRES reporter in RACK1-
silenced cells (Figure 3B). Silencing of RACK1 did not affect
the amount of the 50 IRES reporter luciferase mRNA in the cells,
indicating that RACK1 affects translation, rather than RNA sta-
bility (Figure S3). By contrast, translation driven by the inter-
genic (IGR) IRES (Jan and Sarnow, 2002; Spahn et al., 2004)
was not affected by the level of RACK1 in the cells (Figure 3B).
Polysome profiles from S2 cells and RACK1-silenced stable
derivatives of these cells (Figure S1D) were similar, confirming
that RACK1 does not affect significantly general translation
(Figure 3C). Finally, we prepared cell-free translation extracts
from control and RACK1-depleted S2 cells and used them to
monitor translation of in-vitro-transcribed, capped, and IRES-1088 Cell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc.dependent RNAs. Translation of the 50
IRES reporter RNA was strongly reduced
in the RACK1 depleted extract. By co-
ntrast, translation of the 50 CAP and
IGR IRES-dependent reporters was not
inhibited and was even slightly stimu-
lated (Figure 3D). Overall, our data indi-
cate that ribosomal RACK1 is requiredfor IRES-dependent translation of Dicistroviridae both ex vivo
and in vitro.
RACK1 Is an Essential Host Factor for HCV Infection
RACK1 is an evolutionarily strongly conserved factor, and we
asked whether it plays a role in the translation driven by the
IRES of a mammalian virus. Hepatitis C virus (HCV), a major
cause of liver disease and hepatocellular carcinoma, is a positive
strand RNA virus member of the Flaviviridae family depending on
a highly structured IRES for its translation (Figure S2) (Spahn
et al., 2001). Transfection of an siRNA targeting RACK1markedly
reduced expression of the protein in Huh7.5.1 cells (Figure 4A), a
human hepatocyte-derived cell line highly permissive for HCV
infection (Lindenbach et al., 2005; Wakita et al., 2005). Infection
of RACK1-depleted Huh7.5.1 cells by cell-culture-derived HCV
(Jc1 strain) was strongly and significantly reduced, as revealed
both by immunodetection of the viral core protein (Figure 4A)
and the focus-forming assay performed by infection of naive
Huh7.5.1 cells with supernatants from infected and treated cells
(Figure 4B). A similar inhibition of infection was observed for HCV
Luc-Jc1 (Figure 4C), a well-characterized recombinant virus ex-
pressing a luciferase reporter (Figure S2B). Inhibition of RACK1
expression was as efficient as the silencing of the key HCV
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Figure 3. The Ribosomal Protein RACK1 Is
Required for IRES-Mediated Translation
(A) Stable S2 transformants expressing a shRNA
targeting the 50 UTR of RACK1 were transfected
with vectors expressing three versions of
RACK1 (WT, D108Y, or R38D/K40E). Expression
of the transfected RACK1 was monitored by
western blot using an antibody recognizing the
N-terminal tag HA. The cells were infected with
CrPV for 16 hr, and viral RNA loads were
determined by qRT-PCR. Data represent the
mean and SEM from three independent experi-
ments.
(B) RACK1 is required for translation regulated by
the 50 IRES, but not the IGR IRES, of CrPV. S2
cells were treated with dsRNAs corresponding to
GFP (control), AGO2, eIF4E, or RACK1 for 3 days
before transfection of the indicated Luciferase
reporters (50CAP, IRESCrPV-IGR, or IRESCrPV-50; see
Figure S2). Luciferase activity wasmonitored 48 hr
later. The ratio of the activity of the IRES-depen-
dent luciferase and the 50 cap-dependent lucif-
erase is plotted and normalized to the control for
the three reporters. Data represent the mean and
SD from six independent experiments.
(C) Polysome profiles from S2 cells expressing or
not expressing a shRNA targeting the 50 UTR of
RACK1. The position of the peaks corresponding
to the 80S ribosomes and the polysomes are
indicated.
(D) In vitro translation of capped and IRES-dependent reporters using cell-free extracts prepared from control or RACK1-silenced S2 cells.
Data represent the mean and SD from three independent experiments. ns, nonsignificant; *p < 0.05 and **p < 0.01. See also Figures S2 and S3.host factors CD81 (Koutsoudakis et al., 2007) and Cyclophilin A
(CypA) (Kaul et al., 2009) (Figures 4A–4C). We next transiently
depleted RACK1 in Huh7.5.1 cells replicating the reporter virus
HCVLuc-Jc1 and observed amarked impairment of HCV replica-
tion (Figure 4D), demonstrating that RACK1 is required for HCV
translation/replication rather than entry. HCV replication rebound
observed after day 4 was due to progressive loss of RACK1
silencing, leading to neosynthesis of RACK1 (Figure S4A).
To confirm that the inhibition of HCV replication is indeed
mediated by the effect of RACK1 on IRES-mediated translation,
we established stable cell lines expressing an IRESHCV-lucif-
erase reporter construct or a classical capped reporter gene
(Figure S2C) and transfected these cells with RACK1-specific
siRNAs. Silencing of RACK1 markedly and specifically de-
creased IRESHCV-dependent translation to a similar extent as
an antiviral siRNA directed against the IRESHCV (Figure 4E). By
contrast, silencing of ribosomal protein RPS3 inhibited transla-
tion from both IRES- and 50 cap-dependent reporter constructs
(Figure 4E). Similar results were obtained when in-vitro-tran-
scribed reporter mRNAs were transfected into Huh7.5.1 cells,
ruling out an effect of RACK1 on transcription of the IRESHCV-
luciferase reporter gene (Figure 4F).
Importantly, RACK1-specific siRNAs did not affect cell prolif-
eration (Figure S4B) or viability, in contrast to silencing of the ri-
bosomal protein RPS3 (Figure 4G). A genome-wide microarray
analysis of polysomes prepared from control or RACK1-silenced
human Huh7.5.1 cells revealed that the amount in polysomes of
mRNAs for most genes, including house-keeping genes and
important hepatocyte-specific genes such as albumin or lipopro-Cteins, was not affected by RACK1 depletion (Figure 4H). Of note,
silencing of RACK1 also did not affect the presence of 50 terminal
oligopyrimidine tract (TOP) mRNAs in polysomes (for details, see
Supplemental Information). This result suggests that translation
of the large majority of mRNAs is not affected by the absence
of RACK1 in human hepatocytes under normal culture condi-
tions and confirms the results obtained in the model organism
Drosophila.
The Effect of RACK1 on Viral Translation Is Independent
of the miRNA Pathway
While this work was in progress, a role for RACK1 inmiRNA func-
tion was reported in the plant Arabidopsis thaliana (Speth et al.,
2013), the model organism Caenorhabditis elegans (Chu et al.,
2014; Jannot et al., 2011), and humans (Otsuka et al., 2011). In
light of the important impact of the cellular microRNA miR122
on HCV replication (Jopling et al., 2005), this suggested that
RACK1 might operate on viral translation through the miRNA
pathway. We first verified that RACK1 affects the miRNA
pathway in Drosophila. Expression in S2 cells of two previously
described miRNA reporters, Par-6 and nerfin-1 (Eulalio et al.,
2007), was derepressed when RACK1 was silenced, indicating
that, in Drosophila as well, RACK1 is involved in miRNA function
(Figures 5A and 5B). We note, however, that the derepression is
much stronger for the miR1 reporter than for the miR9b reporter,
suggesting that the role of RACK1 may be specific of a subset of
miRNAs. By contrast, silencing of Dcr-1 or AGO1 derepressed
equally well the two miR reporters (Figures 5A and 5B). We
next tested whether miRNAs play a role in viral replication byell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc. 1089
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Figure 4. RACK1 Is a Specific Host Factor Required for IRES-
Mediated Translation of HCV
(A–C) Huh7.5.1 cells were transfected with siRNAs either control (siCTRL) or
targeting RACK1 (siRACK1-1 or -2), CD81 (siCD81), Cyclophylin A (siCypA), or
HCV IRES (siHCV) before infection 3 days later with HCV Jc1 (A and B) or HCV
Luc-Jc1 (C). Viral infection was monitored 3 days postinfection by immuno-
blotting using antibodies recognizing HCV core protein (A), by counting foci
forming units (ffu/ml) (B), or by quantifying luciferase activity (C).
(D) HCV Luc-Jc1 replicating cells were transfected with siCTRL and two
different siRNAs targeting RACK1 or siCypA, and replication was monitored
during 5 days by luciferase activity quantification.
(E) Huh7.5.1. cell lines stably expressing an IRES (IRESHCV-Luc) or a 5
0 cap
(CTRL-Luc)-dependent luciferase reporter genewere transfectedwith siCTRL,
siRACK1, siHCV, siRPS3, or siLuc. Translation was monitored 72 hr later by
luciferase activity quantification.
(F) Huh7.5.1 cells were transfected with the indicated siRNAs and 72 hr later
with in-vitro-transcribed IRESHCV or 5
0 cap-dependent luciferase mRNAs.
Luciferase activity was monitored 5 hr later.
(G) Cell viability of Huh7.5.1 cells silenced with the indicated siRNAs was
measured during 5 days using MTT assay. **p < 0.01 and ***p < 0.005. For (B)–
(G), data represent the mean ± SD of at least three experiments.
1090 Cell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc.monitoring accumulation of viral RNAs in cells depleted of Dcr-1
or AGO1. Silencing of Dcr-1 had no effect on the viral RNA load
of the four viruses tested (Figure 5C). Silencing of AGO1 did
reduce, to some extent, CrPV and DCV RNA load. However,
this reduction was variable in the case of DCV and not to the
extent of the reduction observed when RACK1 was silenced
for DCV and CrPV (Figure 5C). Thus, although the miRNA
pathway may have a contribution in the replication of Dicistrovir-
idae, our data suggest that the strong effect of RACK1 cannot be
accounted for only by its effect on miRNA function. This was
confirmed by the observation that silencing of Dcr-1 or AGO1
had no effect on translation driven by the IRESCrPV-50, unlike
silencing of RACK1 (Figure 5D).
In mammalian hepatocytes, HCV translation depends on
AGO2 and miR122 (Conrad et al., 2013; Roberts et al., 2011).
As expected, transfection of Huh7.5.1 cells with a miR122 mimic
increased HCV replication, whereas transfection of a miR122 in-
hibitor led to decreased viral replication (Figure 5E). Importantly,
the impact of themiR122mimic and themiR122 inhibitor on HCV
replication did not depend on RACK1 (Figure 5E). To unambigu-
ously determine whether the contribution of RACK1 to HCV
translation was dependent on miR122, we used HEK293T cells,
which do not express miR122 (Da Costa et al., 2012; Figure S5).
Silencing of RACK1 expression efficiently repressed translation
driven by the IRESHCV in these cells (Figure 5F). Finally, transduc-
tion of HEK293T cells with an expression vector for miR122
did not affect the impact of RACK1 on HCV translation (Fig-
ure 5G), although miR122 was expressed and functional in these
cells (Figures S5A and S5B). Collectively, these results indicate
that RACK1 and miR122 regulate HCV translation by different
mechanisms.
The eIF3j Subunit Is Dispensable for Cell Viability but Is
Important for CrPV and HCV Replication
We next attempted to gain mechanistic insight on the role of
RACK1 in viral translation. Previous cryo-electron microscopy
studies have highlighted the interaction of the 40S subunit with
the HCV IRES and, in spite of their low resolution, have sug-
gested that binding of the HCV IRES triggers a pronounced
conformational change in the small subunit of the ribosome
(Spahn et al., 2001, 2004). HCV IRES has been also visualized
on the 80S human ribosome and RACK1 localized in its vicinity
(Boehringer et al., 2005; Sengupta et al., 2004). The recently
elucidated crystal structure of the small subunit of the ribosome
at 3.9A˚ (Rabl et al., 2011) allows us to fit the crystal structure
in the cryo-electron microscopy density. The picture obtained
suggests that RACK1 is located in close proximity to the IRES
of HCV in the region affected by the conformational change
triggered upon IRESHCV binding (Figure S6A). By contrast, the
IRESCrPV-IGR, which does not depend on RACK1 (Figure 2C), in-
teracts with a distinct site of the 40S subunit, directly contacting(H) Quantification of representative mRNAs in polysomes prepared from
Huh7.5.1 cells transfected with siCTRL or siRACK1. Gene expression levels,
shown in arbitrary units, were determined by hybridization on genome-wide
microarrays and represent the mean ± SD of four individual samples.
Each sample was analyzed individually. See also Figures S2 and S4 and
Table S2.
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Figure 5. The Effect of RACK1 on Viral Translation Is Independent of
the miRNA Pathway
(A and B) RACK1 is required for miR1 andmiR9b silencing. The structure of the
Par-6 30 UTR and nerfin-1 30 UTR reporter constructs is represented on top,
and the luciferase activity in cells silenced for the indicated genes is shown
below.
(C) Effect of the depletion of AGO1, Dcr-1, and RACK1 on replication in
Drosophila S2 cells of CrPV, DCV, FHV, and VSV. Cells were transfected with
the indicated dsRNAs and infected 4 days later. Viral RNAwas extracted 24 hpi
and was quantified by qRT-PCR.
(D) Silencing of AGO1 or Dcr-1 does not affect the activity of a Luciferase
reporter gene controlled by the IRESCrPV-50 in Drosophila S2 cells.
(E) A miR122 mimic and a miR122 inhibitor affect HCV replication similarly in
control or RACK1-silenced Huh7.5.1 hepatocytes.
(F and G) Silencing of RACK1 affects the activity of the IRESHCV-luciferase
reporter in miR122-deficient (F) and stably transfected miR122 expressing (G)
HEK293T cells, respectively.
Data represent the mean and SEM of at least three independent experiments.
ns, nonsignificant; *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5.RpS25 (Figure S6B) (Ferna´ndez et al., 2014; Koh et al., 2014;
Schu¨ler et al., 2006; Spahn et al., 2004). Although no direct con-
tacts between RACK1 and IRESHCV could be observed, a recent
study indicates that a peripheral domain of the translation initia-Ction factor eIF3, which is required for IRESHCV-dependent
translation (Kieft, 2008), is in contact with RACK1 (Figure S6C)
(Hashem et al., 2013a; Sun et al., 2013). This domain may be
the functional link between RACK1 and IRESHCV-dependent
translation.
We asked whether some subunits of eIF3, such as eIF3c,
which has been shown to interact with RACK1 in yeast, may
be specifically involved in IRES-dependent translation, like
RACK1.We first tested inDrosophila S2 cells whether some sub-
units of the eIF3 complex are dispensable for cell viability in
normal culture conditions. Out of the 14 genes encoding eIF3
components (the Drosophila genome contains two eIF3g pa-
ralogues, CG8636 (eIF3ga) and CG10881 (eIF3gb)), only two
were not required for cell viability or proliferation (Figure 6A).
One of these genes is CG10881, encoding eIF3gb, which is ex-
pressed specifically in testis (Chintapalli et al., 2007) and thus
provides a useful negative control. The second gene is the
Drosophila ortholog of eIF3j (Figure 6A). We next monitored
CrPV replication in cells silenced for eIF3j or eIF3gb
(CG10881). Although silencing of eIF3gb did not affect CrPV
replication, silencing of eIF3j resulted in a significant reduction
of CrPV replication (Figure 6B). Silencing of eIF3j, but not of
eIF3gb, also affected translation of the IRESCrPV50-luciferase re-
porter, although not as strongly as silencing of RACK1 (Fig-
ure 6C). In Huh7.5.1 cells, silencing of eIF3c affected cell viability.
By contrast, silencing of eIF3j only marginally affected cell
viability (Figure 6D; Wagner et al., 2014). Interestingly, however,
it resulted in a moderate but significant decrease of HCV replica-
tion (Figure 6E). Altogether, these results suggest that the eIF3j
subunit might participate in the observed effects of RACK1 on
translation.
DISCUSSION
A Function for RACK1 in IRES-Dependent Translation
Our data reveal a function for RACK1 in specific mRNA transla-
tion. Indeed, silencing RACK1 expression does not affect
viability of Drosophila S2 or human Huh7.5.1 cells in tissue cul-
ture, indicating that formation of active ribosomes is not strictly
dependent on RACK1. In vivo as well, translation can occur in
the absence of RACK1, as lethality in RACK1 mutant animals
does not occur before larval stages for Drosophila and gastrula-
tion in mice (Kadrmas et al., 2007; Volta et al., 2013). In agree-
ment with this observation, translation of a 50 cap-dependent
reporter was not affected in the absence of RACK1 in Drosophila
and human cells. Nevertheless, the fact that RACK1 mutant an-
imals cannot complete their development suggests that this pro-
tein is required for the translation of some cellular mRNAs, in
addition to viral IRES-containing RNAs. Interestingly, previous
studies have highlighted the role of another protein from the
40S subunit of the ribosome, RpS25, in IRES-dependent trans-
lation (Landry et al., 2009). Performed on yeast and mammalian
tissue-culture cells with IRES reporter assays, these experi-
ments concluded that RpS25 is essential for the activity of two
viral IRES, IRESHCV and IRESCrPV-IGR. The mechanism used by
RpS25 and RACK1 to promote translation is probably different
because (1) RpS25 is required for IRESCrPV-IGR, unlike RACK1,
and (2) structural data place RpS25 at a distance from RACK1ell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc. 1091
AB C
D E
dsRNA:
IR
E
S
 C
rP
V
5’
-L
uc
ife
ra
se
 a
ct
iv
itt
y
RA
CK
1
eIF
3g
b
GF
P
50,000
0
ns
*
100,000
150,000
200,000
250,000
**
**
eIF
3j 
(1)
eIF
3j 
(2)
CrPV 5’IRES reporter
Vi
ra
l r
ep
lic
at
io
n
(%
R
LU
)
siC
TR
L
siR
AC
K1
MO
CK
20
0
40
60
80
100
sie
IF3
j 
120
***
**
ns
HCV viral replication
C
el
l v
ia
bi
lit
y 
(%
)
siC
TR
L
sie
IF3
j
MO
CK
20
0
40
60
80
100
120
siR
PS
3 
**
***
ns
Huh7.5.1 cell viability
S2 cell viability
dsRNA:
C
el
l v
ia
bi
lit
y 
(%
)
RA
CK
1
eIF
3a
eIF
3c
eIF
3f
eIF
3g
a
eIF
3g
b
eIF
3h
eIF
3i
eIF
3j 
(1)
eIF
3k
eIF
3l
eIF
3mGF
P
eIF
3d
eIF
3e
eIF
3j 
(2)
100
50
0
ns ns ns****
eIF
3b
dsRNA:
C
rP
V
 v
ira
l l
oa
d 
(A
.U
.)
RA
CK
1
eIF
3g
b
GF
P
100
0
ns
***
eIF
3j 
(1)
eIF
3j 
(2)
CrPV viral replication
50
***
Figure 6. eIF3j Is Required for CrPV and HCVReplication, but Not for
Cell Viability
(A) Quantification by the MTS assay of the number of viable cells 5 days after
treatment of S2 cells with the indicated dsRNAs. Two different dsRNA prep-
arations, targeting different regions of the gene, were used for eIF3j.
(B) Quantification by qRT-PCR of CrPV viral RNA levels in S2 cells treated with
the indicated dsRNAs.
(C) Activity of the IRESCrPV50 in S2 cells silenced for the indicated genes.
(D) Quantification of Huh7.5.1 cell viability after silencing of the indicated
genes.
(E) Quantification of HCV replication in Huh7.5.1 cells transfected with the
indicated siRNAs.
Data represent the mean and SD of at least three experiments. See also
Figure S6.on the 40S subunit of the ribosome, providing an explanation for
its importance on the activity of the IRESCrPV-IGR. Several other
ribosomal proteins (e.g., RpL38 and RpL40) were recently pro-
posed to be involved in specific translation of some 50 cap-
dependent mRNAs (Kondrashov et al., 2011; Lee et al., 2013),
indicating that transcript-specific regulation can occur in the
absence of IRES elements. Our data lend support to an evolving
picture of the eukaryotic ribosome, which includes structurally
peripheral components such as RACK1 involved in the modula-1092 Cell 159, 1086–1095, November 20, 2014 ª2014 Elsevier Inc.tion of translation of specific mRNAs (reviewed in Xue and Barna
[2012]). They have implications for the development of new anti-
virals and raise questions on the mechanism underlying the role
of RACK1 in IRES-dependent translation.
RACK1 as a Target for Broad Antiviral Intervention
Our results open interesting therapeutic perspectives for a broad
range of viral infections, including chronic hepatitis C, a major
cause of liver cirrhosis and cancer. Because HCV translation ini-
tiates viral genome neosynthesis via the formation of the replica-
tion complex, RACK1-mediated translation is a crucial step in
virus propagation. Thus, RACK1 is a novel host target for antiviral
therapy, which is complementary to interferon-based therapies
or direct-acting antivirals (DAAs). DAAs have achieved high
response rates with cure in late-stage clinical trials, but high
costs will limit their broad access. In addition, certain patient
groups (e.g., genotype 3, renal failure, hepatic decompensation,
and liver transplantation) will need complementary approaches
(Chung and Baumert, 2014; Liang and Ghany, 2013).
The low variability of host factors targeted by host-targeted
antivirals (HTAs) results in a high genetic barrier to resistance
(Nathan, 2012). Indeed, HTAs effectively inhibit HCV escape
variants (Fofana et al., 2010; Lupberger et al., 2011), as well as
DAA-resistant virus (Xiao et al., 2014a). Furthermore, their com-
plementary mechanism of action results in synergy with DAAs
(Xiao et al., 2014b). Given that HTAs interfere with host targets,
one theoretical caveat is the possibly greater risk of cellular
toxicity as compared to DAAs. Interestingly, our data obtained
in cell culture models did not reveal any major toxicity linked to
RACK1 inhibition. Thus, our proof-of-concept studies in state-
of-the-art cell culture models open a highly attractive and inno-
vative perspective to develop small molecules targeting
RACK1. RACK1 inhibitors may also be of interest for treatment
of infection of many other human or animal viruses using 50
cap-independent mechanisms for the translation of their RNAs.
Mechanistic Insight on the Role of RACK1 in
IRES-Dependent Translation
While this work was in preparation, several reports described a
role for RACK1 in miRNA function. However, our data in
Drosophila and human cells indicate that the role of RACK1 in
IRES-dependent translation does not involve small regulatory
RNAs. Nevertheless, the connection between RACK1 and AGO
proteins is intriguing and suggests that RACK1 may participate
in a checkpoint for the control of the translation of specific
mRNAs by miRNAs or siRNAs.
The ribosome code or filter hypothesis posits that some ribo-
somal proteins have evolved to mediate translation of specific
mRNAs (Mauro and Edelman, 2002; Topisirovic and Sonenberg,
2011; Xue and Barna, 2012). A central unresolved issue of this
hypothesis is the nature of the cis-acting elements defining a
possible ‘‘ribosome code.’’ In the case of RACK1, these cis-acting
elements include viral IRES. Interestingly, the IRESCrPV-IGR is
active in the absence of RACK1, unlike the IRESCrPV-50 or the
IRESHCV. This IRESCrPV-IGR (class I IRES) is capable on its own,
without any initiation factors, of binding directly the 40S subunit
and of recruiting the 60S subunit to form an active 80S ribosome,
thus bypassing the loading of the initiator methionyl-tRNAi
(Jan and Sarnow, 2002; Pestova et al., 2004). By contrast, the
function of IRESHCV (class II IRES) requires two canonical eIFs,
eIF2 and 3, as well as Met-tRNAi (Kieft, 2008). This suggests
that the effect of RACK1 on translation initiation may require
one of these factors. Interestingly, the eIF3 complex binds to
the 40S ribosomal subunit and to the IRESHCV (e.g., Kieft et al.,
2001). Furthermore, RACK1 was shown to associate with one of
the eIF3 subunits in order to assemble a translation preinitiation
complex in yeast (Hashem et al., 2013a; Kouba et al., 2012).
Although our understanding of the molecular structure of the
core of the 13 subunits eIF3 complex has progressed remarkably
in recent years (e.g., Hashem et al., 2013b; Sun et al., 2011), the
role of the noncore subunits remains essentially untested in an-
imals. Interestingly, the subunit eIF3e in the yeast Schizosac-
charomyces pombe is involved in translation of a selected set
of RNAs (Sha et al., 2009; Zhou et al., 2005). More recently,
one of the two eIF3h genes present in zebrafish, eIF3ha, was
shown to encode a factor specifically targeting crystalline iso-
formmRNAs for translation during lens development (Choudhuri
et al., 2013). Our data indicate that, like RACK1, the subunit eIF3j
is not required for cell viability in Drosophila but is required for
CrPV replication and IRESCrPV50-driven translation. This raises
the possibility that RACK1 and eIF3j act together in translation
of a specific subset of mRNAs.
Several observations support a role for eIF3j in selectivemRNA
translation. First, it is located in the decoding center of the 40S
ribosomal subunit, where it can regulate access to the mRNA
binding cleft (Fraser et al., 2007; 2009). Second, it is located at
the periphery of the eIF3 complex, often in substoichiometric
quantities, indicating that it can undergo regulated cycles of as-
sociation and dissociation (Hinnebusch, 2006; Miyamoto et al.,
2005; Sha et al., 2009). Third, experiments in S. pombe and hu-
man cells indicate that it can be regulated posttranslationally
by phosphorylation (Sha et al., 2009) or caspase-mediatedC-ter-
minal truncation (Bushell et al., 2000). Altogether, this suggests
that RACK1may act as a scaffold recruiting an enzymemodifying
eIF3j in order to allow access of the entry channel of the 40S sub-
unit to IRES-containing mRNAs. In a way, such a scenario would
be reminiscent of the recently described role of another eIF3 sub-
unit, eIF3e, which controls the recruitment of the kinase Mnk1 to
phosphorylate eIF4E, thus promoting selectivemRNA translation
in human cells (Walsh and Mohr, 2014).
EXPERIMENTAL PROCEDURES
Silencing Candidate Gene Expression by RNAi and Screening
dsRNAs targeting the candidate genes were designed using the E-RNAi
algorithm (http://www.dkfz.de/signaling/e-rnai3/) (Table S1). Knockdown in
Drosophila S2 cells was performed in 96-well plates using the bathingmethod,
and cells were challenged with virus 4 days later. Viral load was determined by
qRT-PCR. Alternatively, infected cells were fixed and labeled with anti-capsid
antibodies for immunofluorescence analysis using the InCELL1000 Analyzer
workstation (GE LifeSciences). Image data processing was performed using
the InCELL Analyzer software. See Extended Experimental Procedures in Sup-
plemental Information for more details.
Preparation of Cell-free Extract for In Vitro Translation
In vitro translation competent extracts were prepared from control or RACK1-
silenced S2 cells as described inWakiyama et al., (2006). Briefly, cells were re-
suspended in lysis solution (40 mM HEPES-KOH [pH 8], 100 mM potassiumCacetate, 1 mM magnesium acetate, and 1 mM dithiothreitol) at a cell density
of 109 ml1 and were placed in the Cell Disruption Bomb (Parr Instrument
Company). The homogenate produced upon the pressure release was cleared
by centrifugations at 4C, and creatine kinase was added at 0.24 mg.ml1 of
lysate before storage in aliquotes at 80C. Reporter mRNAs were synthe-
sized by transcription in vitro using recombinant T7 RNA polymerase. A
nonfunctional cap (ApppG) (New England Biolabs) was added at the 50 end
of the IRES monocistronic reporter mRNAs to protect them from degradation.
Cap-dependent translation was measured with a Renilla Luciferase reporter
mRNA that was capped with the ScriptCap m7G capping system (Epicenter
Biotechnologies). In vitro translation was performed as previously described
(Wakiyama et al., 2006) and under subsaturating conditions to avoid substrate
titration.
HCV Infection and Replication Assays
Huh7.5.1 human hepatoma cells were infected with cell-culture-derived HCV
(HCVcc strains Jc1 and Luc-Jc1, half-maximal tissue culture infectious dose
[TCID50 104 ml1 for both viruses]) as described (Lupberger et al., 2011;
Pietschmann et al., 2006). Two days before infection, gene silencing was per-
formed by reverse transfection with 10 nM of siRNA (Silencer Select siRNA,
Ambion) specific for RACK1, CD81, Cyclophilin A, HCV IRES, or a nonspecific
control siRNA. Viral infection and RACK1 depletion were analyzed by western
blotting and quantified by counting of focus forming units (ffu)/ml following im-
munostaining using a HCV core-specific antibody (mAbC7-50, Affinity Bio-
Reagents, CO) or by luciferase reporter gene expression in cell lysates
3 days postinfection. For HCV replication experiments, Huh7.5.1 cells were
electroporated with HCV Luc-Jc1 RNA (Koutsoudakis et al., 2007). Cells
were reverse transfected with siRNAs 3 days later. Global analysis of poly-
some-associated mRNAs in control and RACK-1 silenced Huh7.5.1 cells
was performed on Agilent ‘‘SurePrint G3 Human Gene Expression v2’’ 8x60k
microarray (Table S2 and see Extended Experimental Procedures for more
details).
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